BSX | Boston ScientificNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$43.50
-$0.82 (-1.85%)

Boston Scientific (BSX) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Oct 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $43.50 vs 50 $44.56 / 200 $56.07
Projection
No cross projected
Test
No active test
Last cross
Death cross 16 Oct 2025 ยท projected 28 bars out ยท tested 4 bars

Weekly as of 30 Oct 16:00 ET

Price
below both $41.98 vs 50 $63.04 / 200 $72.27
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 31 Aug 2026 ยท projected 30 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $43.50 vs 50 $43.62 / 200 $45.52
Projection
No cross projected
Test
No active test
Last cross
Death cross 23 Sep 2025 ยท projected 19 bars out

Cross history

19
crosses on record since 2018
8 golden11 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
week of 31 Aug 2026Death steepweekly30 bars outNot tested
16 Oct 2025Death moderatedaily28 bars out4 bar cross test
23 Sep 2025Death4-hour19 bars outโ€”
13 May 2025Golden4-hour30 bars outโ€”
24 Apr 2025Death4-hour13 bars outโ€”

About BSX

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$806M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.